Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Annals of Behavioral Medicine
Erschienen in: Annals of Behavioral Medicine 3/2012

01.06.2012 | BRIEF REPORT

History of Major Depressive Disorder Prospectively Predicts Worse Quality of Life in Women with Breast Cancer

verfasst von: Heather S. L. Jim, Ph.D., Brent J. Small, Ph.D., Susan Minton, D.O., Michael Andrykowski, Ph.D., Paul B. Jacobsen, Ph.D.

Erschienen in: Annals of Behavioral Medicine | Ausgabe 3/2012

Einloggen, um Zugang zu erhalten

Abstract

Background

Data are scarce about whether past history of major depressive disorder in the absence of current depression places breast cancer patients at risk for worse quality of life.

Purpose

The current study prospectively examined quality of life during chemotherapy in breast cancer patients with a history of resolved major depressive disorder (n = 29) and no history of depression (n = 144).

Methods

Women with Stages 0–II breast cancer were assessed prior to and at the completion of chemotherapy. Major depressive disorder was assessed via structured interview and quality of life with the SF-36.

Results

Patients with past major depressive disorder displayed greater declines in physical functioning relative to patients with no history of depression (p ≤ 0.01).

Conclusions

Findings suggest that breast cancer patients with a history of resolved major depressive disorder are at increased risk for declines in physical functioning during chemotherapy relative to patients with no history of depression.
Literatur
1.
Oleske DM, Cobleigh MA, Phillips M, Nachman KL. Determination of factors associated with hospitalization in breast cancer survivors. Oncol Nurs Forum. 2004; 31:1081–1088.PubMedCrossRef
2.
Bui QU, Ostir GV, Kuo YF, Freeman J, Goodwin JS. Relationship of depression to patient satisfaction: Findings from the barriers to breast cancer study. Breast Cancer Res Treat. 2005; 89: 23–28.PubMedCrossRef
3.
Grabsch B, Clarke DM, Love A, et al. Psychological morbidity and quality of life in women with advanced breast cancer: A cross-sectional survey. Palliat Support Care. 2006; 4: 47–56.PubMedCrossRef
4.
Frick E, Tyroller M, Panzer M. Anxiety, depression and quality of life of cancer patients undergoing radiation therapy: A cross-sectional study in a community hospital outpatient centre. Eur J Cancer Care (Engl). 2007; 16: 130–136.CrossRef
5.
Goodwin JS, Zhang DD, Ostir GV. Effect of depression on diagnosis, treatment, and survival of older women with breast cancer. J Am Geriatr Soc. 2004; 52: 106–111.PubMedCrossRef
6.
Colleoni M, Mandala M, Peruzzotti G, et al. Depression and degree of acceptance of adjuvant cytotoxic drugs. Lancet. 2000; 356: 1326–1327.PubMedCrossRef
7.
Watson M, Haviland JS, Greer S, Davidson J, Bliss JM. Influence of psychological response on survival in breast cancer: A population-based cohort study. Lancet. 1999; 354: 1331–1336.PubMedCrossRef
8.
Phillips KA, Osborne RH, Giles GG, et al. Psychosocial factors and survival of young women with breast cancer: A population-based prospective cohort study. J Clin Oncol. 2008; 26: 4666–4671.PubMedCrossRef
9.
Watson M, Homewood J, Haviland J, Bliss JM. Influence of psychological response on breast cancer survival: 10-year follow-up of a population-based cohort. Eur J Cancer. 2005; 41: 1710–1714.PubMedCrossRef
10.
11.
Andersen BL. Predicting sexual and psychologic morbidity and improving the quality of life for women with gynecologic cancer. Cancer. 1993; 71: 1678–1690.PubMedCrossRef
12.
Costanzo ES, Lutgendorf SK, Mattes ML, et al. Adjusting to life after treatment: Distress and quality of life following treatment for breast cancer. Br J Cancer. 2007; 97: 1625–1631.PubMedCrossRef
13.
Kenne Sarenmalm E, Ohlen J, Oden A, Gaston-Johansson F. Experience and predictors of symptoms, distress and health-related quality of life over time in postmenopausal women with recurrent breast cancer. Psychooncology. 2008; 17: 497–505.
14.
Okamura M, Yamawaki S, Akechi T, Taniguchi K, Uchitomi Y. Psychiatric disorders following first breast cancer recurrence: Prevalence, associated factors and relationship to quality of life. Jpn J Clin Oncol. 2005; 35: 302–309.PubMedCrossRef
15.
Okano Y, Okamura H, Watanabe T, et al. Mental adjustment to first recurrence and correlated factors in patients with breast cancer. Breast Cancer Res Treat. 2001; 67: 255–262.PubMedCrossRef
16.
Jacobsen PB, Donovan KA, Small BJ, et al. Fatigue after treatment for early stage breast cancer: A controlled comparison. Cancer. 2007 110: 1851–1859.PubMedCrossRef
17.
Katz JN, Chang LC, Sangha O, Fossel AH, Bates DW. Can comorbidity be measured by questionnaire rather than medical record review? Med Care. 1996; 34: 73–84.PubMedCrossRef
18.
First MB, Gibbon M, Spitzer RL, Williams JB. User's Guide for the Structured Clinical Interview for the DSM-IV Axis I Disorders - Research Version. New York: Biometrics Research Department, New York State Psychiatric Institute, 1996.
19.
Radloff LS: The CES-D Scale. A self report depression scale for research in the general population. Appl Psychol Meas. 1977; 1: 119–135.CrossRef
20.
Beeber L, Shea J, McCorkle R. The Center for Epidemiological Studies Depression Scale as a measure of depressive symptoms in newly diagnosed patients. J Psychosoc Oncol. 1998; 16: 1–20.CrossRef
21.
Hann D, Winter K, Jacobsen P. Measurement of depressive symptoms in cancer patients: Evaluation of the Center for Epidemiological Studies Depression Scale (CES-D). J Psychosom Res. 1999; 46: 437–443.PubMedCrossRef
22.
Ware JE, Snow KK, Kosinski M, Gandek B. SF-36 Health Survey: Manual and Interpretation Guide. Boston: The Health Institute, 1993.
23.
Ware JE, Kosinski M, Keller SD. SF-36 Physical and Mental Health Summary Scales: A User's Manual. Boston: The Health Institute, 1994.
24.
Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: Conceptual, strategic, and statistical considerations. J Pers Soc Psychol. 1986; 51: 1173–1182.PubMedCrossRef
25.
MacKinnon DP, Fairchild AJ, Fritz MS. Mediation analysis. Annu Rev Psychol. 2007; 58: 593–614.PubMedCrossRef
26.
Sobel ME. Asymptotic confidence intervals for indirect effects in structural equation models. Sociol Methodol. 1982; 13: 290–312.CrossRef
27.
Burnam MA, Wells KB, Leake B, Landsverk J. Development of a brief screening instrument for detecting depressive disorders. Med Care. 1988; 26: 775–789.PubMedCrossRef
28.
Cho HJ, Lavretsky H, Olmstead R, et al. Sleep disturbance and depression recurrence in community-dwelling older adults: A prospective study. Am J Psychiatry. 2008; 165: 1543–1550.PubMedCrossRef
29.
Solomon DA, Keller MB, Leon AC, et al. Multiple recurrences of major depressive disorder. Am J Psychiatry. 2000; 157: 229–233.PubMedCrossRef
30.
Cho HJ, Lavretsky H, Olmstead R, et al. Prior depression history and deterioration of physical health in community-dwelling older adults--a prospective cohort study. Am J Geriatr Psychiatry. 2010; 18: 442–451.PubMedCrossRef
31.
Post RM. Transduction of psychosocial stress into the neurobiology of recurrent affective disorder. Am J Psychiatry. 1992; 149: 999–1010.PubMed
32.
Monroe SM, Harkness KL. Life stress, the "kindling" hypothesis, and the recurrence of depression: Considerations from a life stress perspective. Psychol Rev. 2005; 112: 417–445.PubMedCrossRef
33.
Navari RM, Brenner MC, Wilson MN. Treatment of depressive symptoms in patients with early stage breast cancer undergoing adjuvant therapy. Breast Cancer Res Treat. 2008; 112: 197–201.PubMedCrossRef
34.
Morrow GR, Hickok JT, Roscoe JA, et al. Differential effects of paroxetine on fatigue and depression: A randomized, double-blind trial from the University of Rochester Cancer Center Community Clinical Oncology Program. J Clin Oncol. 2003; 21: 4635–4641.PubMedCrossRef
35.
Roscoe JA, Morrow GR, Hickok JT, et al. Effect of paroxetine hydrochloride (Paxil) on fatigue and depression in breast cancer patients receiving chemotherapy. Breast Cancer Res Treat. 2005; 89: 243–249.PubMedCrossRef
36.
Jacobsen PB, Jim HS. Psychosocial interventions for anxiety and depression in adult cancer patients: Achievements and challenges. CA Cancer J Clin. 2008; 58: 214–230.PubMedCrossRef
Metadaten
Titel
History of Major Depressive Disorder Prospectively Predicts Worse Quality of Life in Women with Breast Cancer
verfasst von
Heather S. L. Jim, Ph.D.
Brent J. Small, Ph.D.
Susan Minton, D.O.
Michael Andrykowski, Ph.D.
Paul B. Jacobsen, Ph.D.
Publikationsdatum
01.06.2012
Verlag
Springer-Verlag
Erschienen in
Annals of Behavioral Medicine / Ausgabe 3/2012
Print ISSN: 0883-6612
Elektronische ISSN: 1532-4796
DOI
https://doi.org/10.1007/s12160-011-9333-6

Weitere Artikel der Ausgabe 3/2012

Annals of Behavioral Medicine 3/2012 Zur Ausgabe

Invited Commentary

Commentary on Manne et al.: Using the Interdependence Model to Understand Spousal Influence on Colorectal Cancer Screening Intentions: a Structural Equation Model

Invited Commentary

Type-D Personality and Heart Disease: It Might Be ‘One Small Step’, but It Is Still Moving Forward: A Comment on Grande et al.

Invited Commentary

Invited Commentary on Jaser et al.: Coping, Self-management, and Adaptation in Adolescents with Type 1 Diabetes

Original Article

Using the Interdependence Model to Understand Spousal Influence on Colorectal Cancer Screening Intentions: A Structural Equation Model

Original Article

The Effect of Patient–Provider Communication on Medication Adherence in Hypertensive Black Patients: Does Race Concordance Matter?

Original Article

I (should) Need a Cigarette: Adolescent Social Anxiety and Cigarette Smoking

Neu in den Fachgebieten Neurologie und Psychiatrie

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Bildnachweise